Diabetes patients using Hypurin Porcine Isophane insulin cartridges have been urged to check their medication is correct by the Medicines and Healthcare products Regulatory Agency (MHRA) after a packaging error came to light
The issue occurred when a carton for cartridges of intermediate acting Hypurin Porcine Isophane Insulin 100 IU/ml got into the production line for the short acting Hypurin Porcine Neutral Insulin 100IU/ml.
The result of taking the wrong medication could result in a patient experiencing insulin wearing off sooner than expected.
One carton of the faster-acting insulin was intercepted by a pharmacist before it reached the patient.
Wockhardt UK , the manufacturer of the drug, said it was unlikely any more cartons had made their way onto the production line. However, the MHRA said that the supply chain, patients and pharmacists should check their cartons.
The issue related to one batch of Hypurin Porcine Neutral Insulin, with the batch number PL40147. The MHRA issued a drug alert following a precautionary recall by the manufacturer.
Gerald Heddell, MHRA director of inspection, enforcement and standards said: "It is important that patients continue to administer their insulin as required. Patients with any questions or concerns should contact their GP or pharmacist as soon as possible. An investigation has taken place and action has been taken to rectify the issue."
